SONJA M. HAGINS (Contracting Officer)

Sonja M. Hagins serves as a Contracting Specialist responsible for managing the acquisition of critical medical and laboratory products and services to support public health infrastructure. She plays a pivotal role in ensuring timely and compliant procurement of high-priority healthcare supplies, aligning acquisitions with federal regulatory standards and mission-driven objectives. Her portfolio primarily encompasses contracts for blood and organ banking operations, in-vitro diagnostic substances, surgical instruments, and medical laboratory services. Hagins exercises full lifecycle contract management, from requirements definition and market research to solicitation, evaluation, award, and administration, ensuring adherence to FAR and agency-specific procurement policies. While specific contractor names are not publicly disclosed, Hagins maintains consistent working relationships with a diverse range of vendors specializing in biomedical manufacturing and clinical diagnostics. Her procurement approach emphasizes technical competency, regulatory compliance, and supply chain reliability, fostering partnerships with both large-scale manufacturers and specialized small businesses capable of meeting stringent quality and certification standards for medical-grade products. Hagins demonstrates a strong preference for open competition, with 100% of her acquisitions conducted under non-set-aside authorities. This reflects a strategic focus on maximizing competition and ensuring access to the broadest possible pool of qualified suppliers, rather than targeting specific socioeconomic categories such as 8(a), HUBZone, or SDVOSB programs. Her contracting patterns prioritize technical merit and capability over socioeconomic set-asides, while still fully complying with all small business participation goals through unrestricted competition. Her primary NAICS focus lies in Blood and Organ Banks (621991), with significant activity in In-Vitro Diagnostic Substance Manufacturing (325413), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), and Medical Laboratories (621511). She possesses deep expertise in procuring complex, regulated healthcare products requiring FDA oversight, sterile processing standards, and cold chain logistics, making her a key resource in securing mission-critical biomedical capabilities.